Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00744796 · ClinicalTrials.gov registry record

Early Experience With Descemet's Stripping Automated Endothelial Keratoplasty

A clinical trial of Corneal Edema Secondary to Corneal Endothelial Dystrophy, sponsored by University of Texas Southwestern Medical Center.

Completed
Registry status
21
Enrollment target
1
Study location

NCT00744796 is a study of Corneal Edema Secondary to Corneal Endothelial Dystrophy that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 21 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00744796, a study of Corneal Edema Secondary to Corneal Endothelial Dystrophy, has completed, sponsored by University of Texas Southwestern Medical Center.

COMPLETED
Registry status
21 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to report the early clinical outcomes in patients undergoing Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK) for corneal edema secondary to corneal endothelial cell dysfunction, and to correlate this clinical data with the latest generation of imaging modalities available for the anterior segment.

Interventions

  • PROCEDURE DSAEK
  • DIAGNOSTIC_TEST Anterior Segment Optical Coherence Topography (OCT)
  • DIAGNOSTIC_TEST Best Spectacle Corrected Visual Acuity (BSCVA)

Study Locations (1)

Texas

  • UT Southwestern Medical Center - Aston Ambulatory Clinic - Dallas

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2006-12
Est. Completion 2009-07

What the Registry Record Tells You About NCT00744796

The ClinicalTrials.gov registry entry for NCT00744796 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Corneal Edema Secondary to Corneal Endothelial Dystrophy appearing as the primary indexed condition, and to 3 interventions - of which DSAEK is the first listed.

NCT00744796 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT00744796 about?

NCT00744796 is a clinical study titled "Early Experience With Descemet's Stripping Automated Endothelial Keratoplasty". The purpose of this study is to report the early clinical outcomes in patients undergoing Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK) for corneal edema secondary to corneal endothelial cell dysfunction, and to correlate this clinical data with the latest generation of imaging mod...

What is the current status of trial NCT00744796?

This trial is currently completed. The enrollment target is 21 participants. The study started on 2006-12. Estimated completion is 2009-07.

What conditions does trial NCT00744796 study?

This clinical trial studies the following conditions: Corneal Edema Secondary to Corneal Endothelial Dystrophy.

What interventions are being tested in trial NCT00744796?

The interventions under investigation include: DSAEK (PROCEDURE), Anterior Segment Optical Coherence Topography (OCT) (DIAGNOSTIC_TEST), Best Spectacle Corrected Visual Acuity (BSCVA) (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT00744796?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00744796 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.